Loading company…
ID 404388783 · FY 2018–2024 · 7 years
Subsidiary of შეზღუდული პასუხისმგებლობისსაზოგადოება ფილუეტ საიპრეს ლიმიტედ (100.0%)
კომპანიის ძირითადი საქმიანობაა სხვადასხვა ბიოლოგიურად აქტიური საკვები დანამატების და თავის მოვლის საშუალებების იმპორტი და რეალიზაცია.
Bars are revenue on the left axis; lines are EBITDA and net margin on the right.
| Ratio | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Margins | |||||||
| Gross Margin | 29.4% | 28.0% | 31.5% | 30.8% | 15.6% | 11.1% | 12.2% |
| EBITDA Margin | 18.9% | 18.2% | 22.4% | 22.2% | 7.2% | -10.1% | -6.3% |
| EBITDAR | 1,782 | 2,020 | 2,885 | 2,726 | 561 | -415 | -305 |
| EBITDAR Margin | 20.4% | 18.2% | 22.4% | 22.2% | 7.2% | -8.0% | -6.1% |
| EBIT Margin | 18.8% | 17.1% | 21.3% | 20.7% | 0.4% | -24.6% | -14.6% |
| Net Profit Margin | 15.4% | 12.7% | 20.0% | 16.8% | -3.2% | -25.8% | -17.2% |
| Operating Expense % of Sales | 10.5% | 9.8% | 9.1% | 9.0% | 8.4% | 22.4% | 18.5% |
| Returns | |||||||
| Return on Assets (ROA) | 49.1% | 41.4% | 88.3% | 39.5% | -7.7% | -60.0% | -59.9% |
| Return on Equity (ROE) | 95.0% | 85.9% | 158.3% | 84.7% | -53.5% | N/A | N/A |
| ROIC [EBIT / Invested Capital] | 2185.3% | N/A | 1017.8% | 99.9% | 7.7% | N/A | -368.7% |
| Leverage & liquidity | |||||||
| Debt-to-Assets | 0.0% | 7.5% | 4.9% | 5.5% | 8.3% | 33.9% | 136.8% |
| Debt-to-Equity | 0.00x | 0.15x | 0.09x | 0.12x | 0.58x | -0.86x | -1.27x |
| Debt-to-EBITDA | 0.00x | 0.13x | 0.05x | 0.11x | 0.47x | N/A | N/A |
| Equity-to-Assets | 51.7% | 48.2% | 55.8% | 46.6% | 14.3% | -39.3% | -108.1% |
| Net Debt | -1,340 | -1,704 | -1,358 | 107 | -14 | 506 | 1,747 |
| Cash & Equivalents | 1,340 | 1,959 | 1,503 | 181 | 280 | 248 | 215 |
| Total Debt | N/A | 255 | 144 | 288 | 266 | 754 | 1,962 |
| Efficiency & working capital | |||||||
| Inventory Turnover | 5.46x | 7.00x | 7.10x | 3.33x | 5.79x | 3.82x | 4.95x |
| Days Inventory Outstanding (DIO) | 66.8 | 52.1 | 51.4 | 109.6 | 63.0 | 95.5 | 73.7 |
| Receivables Turnover | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Days Sales Outstanding (DSO) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Payables Turnover | 4.66x | 5.37x | 8.00x | 5.77x | 3.60x | 1.96x | 4.93x |
| Days Payable Outstanding (DPO) | 78.3 | 67.9 | 45.6 | 63.2 | 101.4 | 186.3 | 74.0 |
| Cash Conversion Cycle | -11.5 days | -15.8 days | 5.8 days | 46.4 days | -38.4 days | -90.8 days | -0.3 days |
| Asset Turnover | 3.19x | 3.25x | 4.41x | 2.35x | 2.43x | 2.32x | 3.48x |
| Cash flow & dividends | |||||||
| Operating Cash Flow | 1,487 | 2,305 | 1,995 | 1,234 | 2,085 | -73 | -1,066 |
| Free Cash Flow (OCF − Capex proxy) | 1,478 | 2,280 | 1,958 | 506 | 2,080 | -224 | -1,127 |
| Cash Conversion (OCF / EBITDA) | 90.1% | 114.1% | 69.1% | 45.3% | 371.7% | N/A | N/A |
| Dividends Declared | 0 | 1,184 | 2,596 | 1,257 | 1,729 | 0 | 0 |
| Dividend Payout Ratio | 0.0% | 83.6% | 100.7% | 61.0% | N/A | N/A | N/A |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in ₾ '000. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Companies sharing this sub-sector, ranked by how close their latest revenue is to this one — not a curated comp set.
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Dividends declared (per SOCE filings): FY2022 ₾1.7m · FY2023 ₾0 · FY2024 ₾0 — 3-yr total ₾1.7m
Ownership & directors from companyinfo.ge (public corporate registry).